BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 46 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | 0.0% | 40,338 | +103.7% | 0.00% | – |
| Q2 2022 | $10,000 | -47.4% | 19,807 | +109.9% | 0.00% | – |
| Q1 2022 | $19,000 | +58.3% | 9,438 | +247.6% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 2,715 | +109.5% | 0.00% | – |
| Q3 2021 | $12,000 | -36.8% | 1,296 | +26.8% | 0.00% | – |
| Q2 2021 | $19,000 | +216.7% | 1,022 | -40.4% | 0.00% | – |
| Q1 2021 | $6,000 | – | 1,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |